DEC 01, 2017 10:05 AM PST

Attacking Persistent Bacteria

WRITTEN BY: Sarah Hertrich

As many of us are aware, the antimicrobial resistance crisis is now regarded as a global public health threat. Bacterial cells involved in persistent infections are of particular concern. These cells are in a quasidormant state, where they are metabolically inactive, allowing the bacteria to avoid the activity of antibiotic drugs.

A new report published in Antimicrobial Agents and Chemotherapy demonstrated that the administration of fumarate increased the efficacy of antibiotics toward killing persistent Pseudomonas aeruginosa cells. Credit: James Archer, CDC.

Chronic or persistent bacterial infections often require a longer treatment course with antibiotics, such as those infections caused by Mycobacterium tuberculosis and Pseudomonas aeruginosa. These persistent species of bacteria have the ability to remain in a state of dormancy or “metabolic hibernation” for weeks or even months in chronically ill patients only to later reemerge in a more aggressive state that can worsen the infection.

Researchers recently sought to determine how they could increase the efficacy of antibiotic treatment of Pseudomonas aeruginosa, which can cause persistent infections in cystic fibrosis (CF) patients. Pseudomonas aeruginosa is able to grow in the mucous that accumulates in the lungs of CF patients and produce biofilms, which are harder to treat using antibiotics.

Interestingly, the research team found that they could completely eradicate persistent Pseudomonas aeruginosa cells when the antibiotic tobramycin was administered with the metabolite fumarate. Out of the 21 clinical isolates tested, only 2 of them did not demonstrate better killing when fumarate was added along with tobramycin.

Fumarate plays a part in the glycolytic pathway where it generates ATP inside bacterial cells, allowing tobramycin uptake through active transport. This finding benefits CF patients specifically, because tobramycin is already approved for use to control chronic Pseudomonas aeruginosa infection in CF patients.

The authors of this study reported that no pathological effects were observed in cell culture upon treatment with tobramycin and fumarate. Although more experiments need to be performed, authors are confident that these results are a promising step toward increasing the efficacy of antibiotics toward persistent bacterial infections.

Sources: mBiosphere, Antimicrobial Agents and Chemotherapy

About the Author
  • I am a postdoctoral researcher with interests in pre-harvest microbial food safety, nonthermal food processing technologies, zoonotic pathogens, and plant-microbe interactions. My current research projects involve the optimization of novel food processing technologies to reduce the number of foodborne pathogens on fresh produce. I am a food geek!
You May Also Like
NOV 19, 2019
Microbiology
NOV 19, 2019
Ketogenic Diet Appears to Help Protect Against the Flu
The ketogenic diet forces the body to use stored fat as fuel instead of carbohydrates; the fat gets broken down into ketone bodies....
NOV 27, 2019
Genetics & Genomics
NOV 27, 2019
Humans Are Continuing to Evolve, Along With Immune-Related Diseases
Humans have evolved in some ways to be less susceptible to pathogens, but those benefits can also carry risks of other diseases....
JAN 07, 2020
Microbiology
JAN 07, 2020
The Unusual Microbiomes of Bats and Birds
Humans might have a critical dependence on the microbes in their guts, but it seems that not all animals do....
JAN 13, 2020
Microbiology
JAN 13, 2020
Using Food to 'Sculpt' the Gut Microbiome
Scientists are learning more about how the antimicrobial effect of some foods and how it alters the microbial community in the gut....
FEB 13, 2020
Genetics & Genomics
FEB 13, 2020
A Very Unusual Virus is Discovered in Brazil
Researchers in Brazil have discovered a very unusual virus infecting amoeba in an artificial lake called Lake Pampulha in the city of Belo Horizonte....
FEB 17, 2020
Microbiology
FEB 17, 2020
Giant Viruses Blur the Line Between Life and Non-Life
Bacteriophages, also known as phages, are more complex than many viruses that we know of, and often carry large genomes....
Loading Comments...